Approval status and evidence for WHO essential medicines for children in the United States, United Kingdom, and Japan: a cross-sectional study
[摘要] Background
The WHO Model List of Essential Medicines for Children (EMLc) covers medicines for globally high-burden diseases. Regulatory approval in high-income countries ensures evidence and dosage form but usually focuses on diseases common in those countries and not in low- and middle-income countries.
[发布日期] [发布机构]
[效力级别] [学科分类] 药理学
[关键词] Drug approval;Essential medicines list;Neglected infectious diseases;Pharmacopoeias [时效性]